So, fellow $CYDY's - hang cool. I don't think the last few
So, fellow $CYDY's - hang cool. I don't think the last few days of drama means much. I hope the prez is on the path to recovery - but we don't really know much (and for good reason - his health is also a national security issue).
The prez's situation is so not typical - he gets tested everyday, with the best and fastest testing kits. In the real world we need treatments for people that may have the virus for 5 days or more before they get a test. There are small towns or underserved areas. They don't have unlimited budgets and resources at their beck and call. Real people have limit insurance available to them etc. So keep in mind how atypical his situation is. The world is a big place (hint - its more than just the 52 states) with lots of needs.
things to keep in mind :
a) play the right game (and not try to play someone elses, but the one best for you). If you have a good product (and we do) and a good plan (okay, we sort of do) - play your game. Sometimes thats hard to do. LL's game at the moment is it needs real data to sell to the FDA. That's the only thing it needs. For BLA. For C-19. Its data. Not just some data, but lots of it in high N values. Even NP has said that when loosing his cool. Stay the course with CD12 as long as we are allowed, don't panic. You want that higher N value. You need to prove it works, not just suggest it works.
I don't think the FDA is against us etc. Bring them good data with a high N. Some peer reviewed papers. Make that data public (so other scientists may review it). You have a solid case. You might not need the last few for EUA - but we are going to need data at a reasonable N that people feel good that the results are typical and not just a data blip.
The high quality data , papers etc - thats also how you beat the shorts - remove their thesis.
b) don't panic - look at today's news - there are side effects about virus candidates. Unfortunately the world is a long way from a solid candidate. It has bits here and there, thats all. We have great science, safety and we probably can handle mutations in the virus (thats huge by the way). We don't know the side effect on our gene's etc for some of these new medications/vaccines (they are all doing very tricky things with RNA etc) from the other offerings. It's a long way to the end.
c) understand your products benefits, and then out execute. Do you know who is going to love LL - the insurance companies. We save them money (one shot , take a second shot in a weeks time , go home and stay away from everyone for 2 weeks or so). Understand the needs of your target market.
d) Once you have product market fit or good data its going to work - then spend the money. We have that now with BLA already (in the end game with luck) and even LL - the EIND and M/M trial. So now scale and spend. Raise and spend to get CD12. Raise capital as fast as you can if you need to - because on the other side is your market.
e) the market size on this is huge (unfortunately). C-19 is so huge in size it's scary. And there will only be a few players - because only a few things work. And each one may work best in a situation the other doesn't.
I personally feel we have a place. A pretty good one.
26
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...
Continue Reading
Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...
Continue Reading
Falcon West finally put enough geological meat on the bone to make Avenir reach for its wallet. Avenir Minerals expects to buy 29,388,127 Grid Metals common shares on or about November 30, 2026, taking its non-diluted position to 19.99%. That number is not accidental. It is the usual Canadian strategic-investor ceiling before the conversation starts getting considerably...
Continue Reading
A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...
Continue Reading
A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...
Continue Reading
Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...
Continue Reading
Back-office drudgery rarely gets anyone’s pulse racing, yet it can quietly chew through a small business’s time and cash. That is why Melio’s latest recognition as Software Experts’ top pick for accounts payable automation deserves a look. The product pitch is straightforward: pull bills, approvals, payments and reconciliation into one workflow rather than leaving...
Continue Reading
Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...
Continue Reading
Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....
Continue Reading
Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...
Continue Reading
Top 5 Most Recently Viewed Articles
Cannabix Technologies at the Tennessee Safety and Health Conference Vancouver, British Columbia — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT), a pioneering developer of advanced marijuana and alcohol breath testing devices, is excited to announce its participation in the Tennessee Safety and Health Conference (TSHC). The event is being held...
Continue Reading
Home Depot Reports Q2 Earnings with Analyst Upgrades The Home Depot Inc. HD has recently shared its financial results for the second quarter, which reflect continued strength despite some challenges. The company reported sales of $45.277 billion, a solid increase of 4.9% compared to the previous year. Financial Highlights from Home Depot’s Q2 Home Depot's earnings...
Continue Reading
Unveiling Exceptional MICE Venues in Latin America MICE tourism is experiencing remarkable growth in Latin America, attracting event organizers and participants from across the continent. Venues in this region offer a unique blend of cultural richness and stunning environments, making them perfect choices for social and corporate events alike. Here, we delve into some of...
Continue Reading
The Impermanence of Bitcoin in the Evolving Market Bitcoin, known for its monumental rise and significant volatility, is facing questions about its future as a dominant player in the crypto market. A recent analysis suggests that the current market correction isn't merely a dip, but a sign that traders and institutions are reassessing their commitment to Bitcoin....
Continue Reading
Overview of the Data Breach Recently, alarming news emerged from the U.N. aviation agency regarding a significant security incident. Reports indicate that 11,929 individuals have been directly impacted by the unauthorized release of recruitment application data records spanning from April 2016 to July 2024. Details of the Security Incident The International Civil Aviation...
Continue Reading